Option chain shows key data for Cyber Apps World Inc's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Cyber Apps World Inc.

Cyber Apps World Inc (OTC:CYAP) Stock, Option Chain

Cyber Apps World Inc

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) and Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) spot ETFs faced substantial net outflows of $742 million on Jan.8.
<a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42840886/bitcoin-spot-etf-inflows-hit-987-million-but-watch-this-mid-january-fiscal-deadline">Bitcoin ETFs</a> led the decline, recording $583 million in outflows, with Blackrock&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>), Fidelity&#8216;s (CBOE: FBTC), and Ark &amp; 21Shares (CBOE: ARKB) contributing $124 million, $258 million and $148 million, respectively, according to <a href="https://sosovalue.com/assets/etf/us-btc-spot?from=moved">data</a> from SoSo Value.
<a href="https://www.benzinga.com/money/what-is-ethereum-etf">Ethereum spot ETFs</a> saw $159 million in withdrawals, $147 million of which stemmed from Fidelity&#8216;s (CBOE: FETH), data shows.
This comes as <a href="https://blog.cex.io/ecosystem/bitcoin-supply-shock-34857">research</a> from the cryptocurrency exchange CEX.IO suggests a Bitcoin supply shock is unlikely in 2025, despite market fluctuations and ETF movements.
CEX.IO's analysis, released today, indicates that 70% of Bitcoin&#8217;s circulating supply is in free float, providing ample liquidity to mitigate the risk of a supply shock. 
Their research further highlights a 1.75 million Bitcoin decrease in long-term holder (LTH) supply in 2024, signaling potential for significant selling pressure within this group in the upcoming year. 
While U.S. spot ETFs absorbed 2.4 times the annual mined supply of Bitcoin in 2024, they account for less than 4% of overall trading volume. 
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42885028/gary-gensler-says-10000-15000-projects-wont-survive-crypto-market-is-wrapped-up-in-sentiment">Gary Gensler Says 10,000-15,000 Projects Won&#8217;t Survive, Crypto Market Is &#8216;Wrapped Up In Sentiment&#8217;</a>
This suggests that while influential, ETF trading volume is not the dominant force in the market.
The report revealed a redistribution of Bitcoin supply with exchange reserves dropping 21% while over-the-counter (OTC) balances increased by 105%, and about 40% of Bitcoin's transaction volume in 2024 was exchange related. 
CEX.IO also quadrupled its market share in 2024, becoming a top 2 exchange for Bitcoin market depth, with a 61% increase in USD denominated 2% market depth. 
The exchange's report argues that with a substantial amount of Bitcoin held by long-term holders ready to take profits, the market will likely see continued adherence to the traditional 4-year market cycle. 
This analysis states that despite the recent outflows in spot ETFs, these market trends mitigate the risk of a severe supply shock in 2025.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42882375/92000-is-bitcoins-key-support-heres-what-top-analyst-says-will-happen-if-it-fails">$92,000 Is Bitcoin&#8217;s Key Support — Here&#8217;s What Top Analyst Says Will Happen If It Fails</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

$BTC

$ETH

ARK 21Shares Bitcoin ETF ARK 21Shares Bitcoin ETF

ARKB

Fidelity Wise Origin Bitcoin Fund Fidelity Wise Origin Bitcoin Fund

FBTC

Fidelity Ethereum Fund Fidelity Ethereum Fund

FETH

IBIT

Bitcoin, Ethereum ETFs See $742 Million In Outflows, Supply Shock Unlikely In 2025, Report Shows

KKR &amp; Co. Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>) has announced the extension of the tender offer period for its acquisition of FUJI SOFT INCORPORATED, extending the<a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b42892784/kkr-further-extends-second-tender-offer-for-fuji-soft" rel="noreferrer noopener"> deadline from January 9 to January 24.</a>
This decision was made following market conditions, where FUJI SOFT&#8217;s share price has remained above the tender offer price of 9,451 yen.
The extension will allow FUJI SOFT shareholders to make more informed decisions amid ongoing developments, including Bain Capital&#8217;s attempts to acquire the company and recent public statements from both FUJI SOFT and Bain Capital.
Bain Capital, which had previously waived the board&#8217;s support for its offer, is now pursuing a hostile partial takeover to seize control of FUJI SOFT.
See Also:&nbsp;<a target="_blank" href="https://www.benzinga.com/economics/macro-economic-events/25/01/42888800/goldman-sachs-flags-market-correction-risk-as-inflation-trump-policies-stir-uncertainty" rel="noreferrer noopener">Goldman Sachs Flags Market Correction Risk As Inflation, Trump Policies Stir Uncertainty</a>
Bain Capital made it a condition precedent of their tender offer that the Second Tender Offer by the Offeror be unsuccessful or withdrawn, and Bain Capital has expressed its intention to begin its tender offer from late January 2025 or after.
However, KKR, through its vehicle FK Co., remains committed to privatizing the company, despite Bain Capital&#8217;s moves. KKR has no intention of withdrawing its offer and is prepared to continue with the tender offer even if it is unsuccessful initially.
As the largest shareholder, KKR is confident that Bain Capital&#8217;s offer will not gain traction.
In a notable turn, FUJI SOFT&#8217;s founding family contacted KKR on December 27, 2024, to propose a potential collaboration involving KKR, Bain Capital, and the founding family in a privatization effort.
Despite the uncertainty surrounding Bain Capital&#8217;s intentions, KKR said it remains committed to FUJI SOFT&#8217;s privatization, which aims to enhance corporate value and growth.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/01/42890014/jim-cramer-warns-on-quantum-stories-as-stocks-plunge-we-need-you-out-before-the-froth-goes-away" target="_blank" rel="noreferrer noopener">Jim Cramer Warns On &#8216;Quantum Stories&#8217; As Stocks Plunge: &#8216;We Need You Out Before The Froth Goes Away&#8217;</a></li>
</ul>

Equities

Markets

General

KKR Extends Tender Offer For FUJI SOFT Amid Bain Capital's Hostile Partial Bid

Needham analyst Kyle Peterson reiterates Axos Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AX#NYSE">AX</a>) with a Buy and maintains $85 price target.

Price Target

Reiteration

Analyst Ratings

Needham Reiterates Buy on Axos Financial, Maintains $85 Price Target

Needham analyst Kyle Peterson maintains Alight (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALIT#NYSE">ALIT</a>) with a Buy and lowers the price target from $11 to $9.

ALIT

Needham Maintains Buy on Alight, Lowers Price Target to $9

Needham analyst Serge Belanger reiterates Liquidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LQDA#NASDAQ">LQDA</a>) with a Buy and maintains $19 price target.

LQDA

Needham Reiterates Buy on Liquidia, Maintains $19 Price Target

Following SER-155 administration, there was a statistically significant decrease in fecal albumin, an established biomarker of epithelial barrier integrity, and a positive impact on biomarkers of systemic inflammation and immune homeostasis, in both cases as compared to placebo.

Biotech

Health Care

MCRB

Seres Therapeutics Announced New Translational Biomarker Results For Exploratory Endpoints From Its SER-155 Phase 1b Placebo-controlled Study In Patients Undergoing Allogenic Stem Cell Transplantation

MAIN

Main Street Capital Has Announced Its Private Loan Portfolio Activity For Fourth Quarter Of 2024, Main Street Originated New Or Increased Commitments In Its Private Loan Portfolio Of $123.4M And Funded Total Investments Across Its Private Loan Portfolio With A Cost Basis Totaling $108M

Mantle Ridge beneficially owns approximately $1.3 billion of the outstanding common shares of Air Products and Chemicals.

Mantle Ridge Sends Letter To Air Products Shareholders; Urges Shareholders To Vote Blue Proxy Card

Needham analyst David Saxon reiterates Globus Medical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMED#NYSE">GMED</a>) from Hold to Hold.

GMED

Needham Reiterates Hold on Globus Medicalto Hold

Palo Alto Networks Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) was downgraded to &#8216;hold&#8217; by Deutsche Bank because the cybersecurity stock owned by Nancy Pelosi could be affected by a sector-wide &#8220;consolidation down-cycle&#8221;. This follows <a href="https://www.benzinga.com/topic/nancy-pelosi">Pelosi&#8217;s</a> February 2024 purchase of nearly $1.25 million in call options of PAWN, which expire on Jan. 17.
What Happened: In its 2025 Software Outlook, Deutsche Bank predicts that the cybersecurity sector will underperform broader software this year after a strong 2024. The bank believes that the market overestimated the impact of consolidation in 2024. &#8220;We expect 2025 will remain in a consolidation down-cycle,&#8221; stated Deutsche&#8217;s research note dated Jan. 7.
Ahead of its expiry on Jan. 17, Nancy Pelosi&#8217;s call options have a strike price of $200 apiece and the current share price of $172.83, as of Wednesday&#8217;s close, is still below the strike price.
Cybersecurity consolidation is the process of centralizing and streamlining cybersecurity tools, technologies, and processes to improve an organization&#8217;s security posture. The goal is to create a unified, more efficient, and cost-effective security infrastructure.
&#8220;Consolidation is no doubt a powerful force, but it&#8217;s subject to cyclical peaks and troughs,&#8221; the report said. The bank also said that it struggles to see fundamentals living up to last year&#8217;s expansion. &#8220;We expect market preference in 2025 will tilt in favor of best-of-breed vs. best-of-suite platforms,&#8221; it added.
&#8220;After a year where Security stocks outperformed Apps and Infrastructure, the overall category is more likely to underperform broader Software in 2025, in our view,&#8221; the note added.
See Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/42893264/charlie-mungers-top-pick-costco-reports-strong-december-sales-analysts-expect-a-7-jump-in-january">Charlie Munger&#8217;s Top Pick Costco Reports Strong December Sales: Analysts Expect A 7% Jump In January</a>
Why It Matters: Deutsche Bank cited four factors contributing to this consolidation slowdown, which include easing IT spending, a surge in AI innovation, a temporary pause in mergers and acquisitions following a July 19 outage, and increased competition in pricing.
The <a href="https://www.benzinga.com/news/24/10/41562639/delta-air-lines-sues-crowdstrike-for-500m-over-july-outage-that-disrupted-flights-affecting-1-3m-cus">disruption</a> on July 19 resulted in flight cancellations globally and impacted sectors such as banking, healthcare, and hospitality.
Despite the downgrade, Deutsche Bank acknowledged the strength of Palo Alto Networks and CrowdStrike as leading cybersecurity companies. However, the bank believes that the current market conditions favor smaller, more innovative players.
Price Action: Shares of Palo Alto advanced 2.82% over the last six months, underperforming the Nasdaq 100 index which gained 3.56% in the same period.
According to <a href="https://www.benzinga.com/quote/PANW/analyst-ratings">Benzinga</a>, Palo Alto has a consensus price target of $373.63 apiece based on the ratings of 42 analysts.
The high is $450 per share issued by RBC Capital on Nov. 21, 2024, and the low is $130 apiece issued by Guggenheim on Jan. 7, 2025.
The average price target of $150 between Deutsche Bank and Guggenheim implies a 13.14% downside for PANW.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/quote/PANW/analyst-ratings"><img loading="lazy" decoding="async" width="946" height="352" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/09062719/panw-anr.png" alt="" class="wp-image-725841" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/09062719/panw-anr.png 946w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/09062719/panw-anr-300x112.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/09062719/panw-anr-768x286.png 768w" sizes="(max-width: 946px) 100vw, 946px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/42891870/avadel-pharmaceuticals-misses-earnings-estimate-but-posts-150-increase-in-sales-from-its-narcolepsy-drug-lumryz" target="_blank" rel="noreferrer noopener">Avadel Pharmaceuticals Misses Earnings Estimates But Posts 150% Sales Increase From Narcolepsy Drug LUMRYZ</a></li>
</ul>
Photo courtesy: Shutterstock

Market Summary

Downgrades

PANW

Nancy Pelosi's Stock Pick Palo Alto Networks Gets A Downgrade From Top Investment Bank As Sector-Wide Consolidation Down-Cycle Weighs on Sentiment

Enhancements to Veritone Contact enable law enforcement agencies to access stop data analytics in near real-time, swiftly identify trends, implement agency improvements and support its efforts to comply with California's Racial and Identity Profiling Act (RIPA)

VERI

Veritone Launches Contact Analytics To Provide California Law Enforcement With Real-Time Data Insights

Total retail sales for the full year 44,851 in 2024, down 15% versus 2023.&nbsp;

PSNY

Polestar Q4 Retail Sales 12,256 Cars, Up 5.3% YoY; Order Intake Up 37.2%

<ul>
<li>Single agent and combination data from Phase 1b AML/MDS trial presented at ASH 2024 showed potential of LYT-200 to serve broad range of patients across various lines of treatment</li>
<li>LYT-200 is currently being evaluated in two Phase 1/2 trials for the potential treatment of AML/MDS and head and neck cancers</li>
</ul>

PRTC

The FDA Has Granted Fast Track Designation To PureTech Health's LYT-200 For Acute Myeloid Leukemia

RAPP

Rapport Therapeutics' Positron Emission Tomography Trial And Second Multiple Ascending Dose Trial For RAP-219, Demonstrated RAP-219 Achieved Target Receptor Occupancy Associated With Maximal Efficacy In Prior Preclinical Models Within Five Days Of Dosing While Maintaining A Differentiated Tolerability Profile

As of December 31, 2024, Climb Bio had cash, cash equivalents and&nbsp;short-term marketable securities of approximately $212.9 million.
Following its entry into the license agreement, Climb Bio anticipates that its existing cash resources will be sufficient to fund its planned operations, including the development of budoprutug and CLYM116, through 2027.

CLYM

Climb Bio To Make Upfront Cash Payment Of $9M To Mabworks Plus Certain Additional Payments Upon Achievement Of Specified Milestones

On Wednesday, January 8th, U.S. markets ended mixed as investors considered conflicting jobs data and reports of President-elect Trump possibly declaring an economic emergency on inflation. Federal Reserve minutes pointed to inflation concerns, while worries over tariffs and policy changes kept markets cautious.
In economic data, U.S. jobless claims fell below estimates, with initial claims at 201K and continuing claims at 1,867K. December&#8217;s ADP employment change missed forecasts at 122K, while November wholesale inventories matched expectations at -0.2%.
Most S&amp;P 500 sectors ended the day with gains, with the healthcare index leading the advances.
The Dow Jones Industrial Average was up 0.25% and closed at 42,635.20, the S&amp;P 500 closed higher by 0.16% at 5,918.30, while the Nasdaq Composite slid 0.06% to finish at 19,478.88.
Asia Markets Today
<ul>
<li>On Thursday, Japan&#8217;s Nikkei 225 closed lower by 0.87% at 39,621.50, led by losses in the Insurance, Financial Services and Mining sectors.</li>
<li>Australia&#8217;s S&amp;P/ASX 200 fell 0.24%, ending the session at 8,329.20, led by losses in the Industrials, Consumer Staples, and IT sectors.</li>
<li>India&#8217;s Nifty 50 closed lower by 0.59% at 23,674.75, and the Nifty 500 slid 0.78%, closing at 22,058.75. Real Estate, Oil and gas, and Power sectors led the losses.</li>
<li>China&#8217;s Shanghai Composite was down 0.58% and closed at 3,211.39, while the Shenzhen CSI 300 declined 0.25% and finished the day at 3,779.88.</li>
<li>Hong Kong&#8217;s Hang Seng closed the session lower by 0.20% at 19,240.89.</li>
</ul>
Eurozone at 06:00 AM ET
<ul>
<li>The European STOXX 50 was up 0.07%.</li>
<li>Germany&#8217;s DAX declined 0.07%.</li>
<li>France&#8217;s CAC rose 0.25%.</li>
<li>U.K.&#8217;s FTSE index 100 traded higher by 0.63%.</li>
</ul>
Commodities at 06:00 AM ET
<ul>
<li>Crude Oil WTI was trading higher by 0.22% at $73.46/bbl, and Brent was up 0.26% at $76.36/bbl.</li>
<li>Natural Gas declined 1.48% to $3.597.</li>
<li>Gold was trading higher by 0.43% at $2,683.74, Silver was up 0.79% to $30.930, and Copper rose 1.31% to $4.3145.</li>
</ul>
U.S. Futures at 06:00 AM ET
Dow futures were up 0.01%, S&amp;P 500 futures fell 0.08% and Nasdaq 100 futures declined 0.15%.
Forex at 06:00 AM ET
<ul>
<li>The U.S. Dollar Index was up 0.17% to 109.19, USD/JPY slid 0.21% to 158.00, and USD/AUD gained 0.30% to 1.6136.</li>
<li>The U.S. dollar strengthened, driven by rising Treasury yields and tariff concerns tied to President-elect Trump&#8217;s policies, pressuring global currencies like the yen, euro, and pound, which hit multi-month lows.</li>
</ul>
Photo by Steve Heap via Shutterstock

Asia

Emerging Markets

Eurozone

Futures

Commodities

Forex

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Asia Markets Slide, Europe Mixed; Dollar Strengthens - Global Markets Today While Us Slept

Climb Bio Enters Exclusive License Deal With Mabworks For Rights To Develop, Commercialize MIL116 (Now CLYM116) Monoclonal Antibody, In Territory Outside China

Fourth quarter production was 824,529 silver ounces and 9,075 gold ounces for 1.6 million silver equivalent production ounces.
Q4 2024 Overview
<ul>
<li>Production At Higher End of Updated Guidance: Lower Guanaceví production from August to December due to a trunnion failure of the primary ball mill. Production resumed to full capacity in December and Q4 2024 production amounted to 718,797 silver ounces and 2,622 gold ounces.</li>
<li>Bolañitos Provides Strong Results: With throughput remaining steady, silver equivalent oz produced were in line with plan. Gold production remained above plan, driven by higher gold grades. Conversely, silver production remained below plan due to lower silver grades.&nbsp;</li>
<li>Metal Sales and Inventories: Sold 654,519 silver oz and 8,343 gold oz during the fourth quarter. A total of 276,477 silver oz and 1,220 gold oz of bullion inventory and 4,216 silver ounces and 296 gold oz in concentrate inventory were held at year end.&nbsp;</li>
<li>Bought Deal Financing of US$73 Million: Proceeds to be used for general working capital and the advancement of the Pitarrilla Project&nbsp;</li>
</ul>

Earnings

Endeavour Silver Reports Full Year 2024 Production Of 4,471,824 Silver Ounces And 39,047 Gold Ounces, For Silver Equivalent Production Of 7.6M Ounces

Needham analyst Ryan Koontz reiterates Lumentum Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITE#NASDAQ">LITE</a>) with a Buy and maintains $110 price target.

LITE

Needham Reiterates Buy on Lumentum Holdings, Maintains $110 Price Target

Logistics Provider GXO Inks Partnership With Lifestyle Brand Calliope

An announcement from Cyber Apps World (CYAP) is now available. Ippolito Cattaneo recently resigned from his roles as Secretary and director of the ...

Cyber Apps World Announces Leadership Shake-Up

An announcement from Cyber Apps World (CYAP) is now available. Andrea Cattaneo has been appointed as a director, CEO, and President of a company fo...

Comments

Cyber Apps World Inc

Cyber Apps World Inc (CYAP) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga